Newnaphthacenecarboxamide antibiotics, TAN-1518A and B, were isolated from a culture broth of Streptomyces sp. AL-16012.Their structures were elucidated from their reactions and from spectroscopic analyses. The relaxation of supercoiled pBR322 DNAby calf thymus DNA topoisomerase I was inhibited by these metabolites as potently as by camptothecin. However, the decatenation of kinetoplast DNAby calf thymus DNAtopoisomerase II was little affected by these agents. The major metabolite, TAN-1518A, strongly suppressed the growth of various murine and human tumor cells, inducing apoptosis. Unlike camptothecin, TAN-1518A did not stimulate cleavable complex formation in the nuclei of CHO-K1cells and had weak activity in intercalating into DNAstrands. This metabolite arrested the growth of human tumor cell lines in Gl phase of the cell cycle. These results suggest that TAN-1518A and B are novel antitumor agents targeting topoisomerase I.
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Newnaphthacenecarboxamide antibiotics, TAN-1518A and B, were isolated from a culture broth of Streptomyces sp. AL-16012.Their structures were elucidated from their reactions and from spectroscopic analyses. The relaxation of supercoiled pBR322 DNAby calf thymus DNA topoisomerase I was inhibited by these metabolites as potently as by camptothecin. However, the decatenation of kinetoplast DNAby calf thymus DNAtopoisomerase II was little affected by these agents. The major metabolite, TAN-1518A, strongly suppressed the growth of various murine and human tumor cells, inducing apoptosis. Unlike camptothecin, TAN-1518A did not stimulate cleavable complex formation in the nuclei of CHO-K1cells and had weak activity in intercalating into DNAstrands. This metabolite arrested the growth of human tumor cell lines in Gl phase of the cell cycle. These results suggest that TAN-1518A and B are novel antitumor agents targeting topoisomerase I.
DNA topoisomerases are nuclear enzymesresponsible for DNAtopology, and they play an important role in DNAmetabolism in mammaliancells, including replication, transcription and recombination.1* These enzymesin cancer cells have lately attracted considerable attention as intracellular targets for cancer therapeutics, since manydrugs with antitumor properties interact with them.2'3) Although a large number of antitumor agents that inhibit topoisomerase II (Topo II) are known, thus far, few agents that inhibit topoisomerase I (Topo I) have been identified.4~7)
In the search for Topo I inhibitors ofmicrobial origin, we found three metabolites in the culture broth of an actinomycete strain isolated from a soil sample. Two of them, TAN-1518 A and B, were proven to be new metabolites belonging to the tetracycline family ( Fig. 1) . The other one, TAN-1518 X, was identical to SF-2575.8'9) Materials and Methods
Taxonomic Studies
Culture characterization was carried out following the International Streptomyces Project pro- Fermentati on THE JOURNAL OF ANTIBIOTICS MAY 1994 A frozen seed stock (5 ml) of strain AL-16012 was inoculated into a 2-liter Sakaguchi flask containing 500 ml of a sterile seed medium consisting of glucose 2%, soluble starch 3%, soybean flour 1 %, corn steep liquor 0.3%, polypeptone 0.5%, NaCl 0.3%, and CaCO30.5%. The flask was shaken on a reciprocal shaker at 28°C for 48 hours. One liter of the seed culture was transferred to a 200-liter fermenter containing 120liters of a production medium consisting of soluble starch 3% and cotton seed flour 0.5%. The fermentation was carried out at 28°C for 72hours with aeration of 120liters/minute and agitation of 200rpm. The production culture (100liters) was transferred to a 6000-liter fermentor containing 3200 liters of the same medium, and the fermentation was carried out at 24°C with aeration of 3200 liters/minute and agitation of 120 rpm.
Analytical Measurement
The IR spectra were measured in KBrpellets and EI-MSspectra were measured on a JEOLJMS-DX303 instrument. The^-values in the NMRspectra were recorded in ppmdown field from tetramethylsilane (TMS) using, a Bruker AC-300 spectrometer.
Isolation
of TAN-1518 A (1) and B (2) Culture broth (3,200 liters) was extracted with EtOAc (1,200 liters) at pH 2.0. The organic layer was washed with 2%NaHCO3 and water successively, and was concentrated, giving an oily residue. To the residue, hexane was added, and a brown powder (250g) was obtained. This was subjected to silica gel (8 liters) column chromatography, eluted with toluene -EtOAc -formic acid (92 : 8 : 2, 8 liters) and (88 : 12 :2, 10liters) to give crude 1 and a mixture of 2 and TAN-1518X (3). The former was purified by silica gel (800ml) chromatography, eluted with CHC13 -MeOH-formic acid (99 : 1 : 2, 2liters), giving 1 (18 g) as a yellow powder. The latter was evaporated to dryness and the residue was treated with MeOHto exclude precipitate 3 (67 g). The filtered liquid was concentrated, giving a brown powder (4.2 g) containing 2. The powder was chromatographed on a silica gel (200ml) column, and eluted with toluene-EtOAc-formic acid (95 : 5 : 2, 1 liter) and (90 : 10 : 2, 500ml); the latter fraction was concentrated, giving crude 2 (715mg). The crude 2 was applied to preparative HPLC(ODS, YMC-PackS-363, 1-15) with a mobile phase of 73% acetonitrile -0.01 m phosphate buffer (pH 3.0). The fractions containing 2 were concentrated and extracted with EtOAc, giving 2 (70 mg) as a yellow powder.
Alkaline Hydrolysis of 1 A solution of 1 (2g) in 1 n NaOH(13ml) was stirred for 6hours at room temperature. The solution was adjusted to pH 2.0 and extracted with EtOAc(2 x 50ml). The combined organic layers were washed with water, dried over anhydrous sodium sulfate and evaporated, giving a yellow powder (1.9 g). The powder was chromatographed on silica gel (50g), eluted with toluene-EtOAc-formic acid (78 : 20 : 2, 600ml) and (58 : 40 : 2, 600ml). The former fraction was concentrated, giving a mixture of salicylic acid (4) (190mg) and 2-methyl-2-butenoic acid (5) . The mixture of 4 and 5 was again chromatographed on slica gel (6g), eluted with CHCl3 -MeOH (80 : 20, 100ml), affording 4 (50mg) and 5 (100mg) as colorless crystals; 4 was identified with an authentic sample by TLC and 1H NMR. Relaxation Assay of Topo I Topo I activity was measured by detecting the conversion of supercoiled pBR322DNAto its relaxed form. The reaction mixture contained 50mMTris-HCl (pH 8.0), 100mMKC1, 10mMMgCl2, 0.5him dithiothreitol (DTT), 30 /ig/ml bovine serum albumin (BSA), 0.25 /ig pBR322 DNA, 2 \A sample solution, and lunit Topo I, in a total volume of 20\A. The mixture was incubated at 37°C for 40minutes and reactions were stopped by the addition of 4/zl of loading buffer, consisting of 0.25% bromophenol blue, 40% glycerol, and 2.5% SDS. They were electrophoresed in agarose gel at 100 volts (V) for 35minutes in TBE buffer consisting of 89 mMTris-borate (pH 8.9) and 2mMEDTAcontaining 0.1% SDS. Gels were stained with ethidium bromide and washed throughly with distilled water. The DNAband was visualized to minicircle monomers. The reaction mixture contained 50mMTris-HCl (pH 8.0), 100mMKC1, 10mM MgCl2, 0.1 mMEDTA, 1 mMATP, 0.5mM DTT, 30//g/ml BSA, 0.2fig kDNA, 2fi\ sample solution, and 1 unit Topo II, in a total volume of 20/A. The mixture was incubated at 37°C for 20minutes. DNAwas analyzed by agarose gel electrophoresis, as described above. One unit of Topo II activity was defined as the amount of the enzyme that decatenated 0.2fig of kDNAfor 20minutes at 37°C. Cytotoxicity EL4 murine lymphoma, P815 murine mastcytoma, and SW48human colon adenocarcinoma were purchased from the American Type Culture Collection (ATCC). The CHO-K1Chinese hamster ovary cell line was purchased from Flow Laboratories Inc. (Irvine, Scotland). B16 murine melanoma was kindly provided by the Japanese Research Resources Bank. The HeLa S3 human epitheloid carcinoma, WiDr humancolon adenocarcinoma, A549humanlung carcinoma, and G361humanmelanomacell lines were obtained from the Institute for Fermentation, Osaka. All cell lines, except for EL4, P815, and CHO-K1, were cultured with Eagle's minimum essential medium (Eagle's MEM)containing 10% fetal bovine serum (FBS), 2mMglutamine, and 20/xg/ml gentamicin. The EL4, P815, and CHO-K1cell lines were cultured with RPMI-1640 containing FBS, 2mMglutamine, 20/zg/ml gentamicin, and 5 x 10~5m 2-mercaptoethanol. Cells at various concentrations in 0.1 ml of culture mediumwere incubated with TAN-1518 A at 37°C for 72hours in an atmosphere of5% CO2in air. The growth of the cell lines was measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assay. 14)
Detection of DNAFragmentation Cells (106) in 3ml of culture medium were seeded in a 6-well plate. After 18-hours incubation, 1 jjm of TAN-1518A was added, and the cells were incubated for another 18 hours. They were then harvested, and genomic DNAwas isolated, essentially following the method of Miller et al15) The harvested cells were resuspended in 300//I of nuclear lysis buffer consisting of 10mMTris-HCl (pH 8.2), 400mMNaCl, and 2mMEDTA.The cell lysates were digested overnight at 37°C by the addition of 25^1 of 10% SDS and 50/^1 of lOmg/ml proteinase K in distilled water. Then 100^1 of saturated NaCl was added, and the suspension was shaken vigorously. After centrifugation, 350^1 of supernatant was transferred to another tube and 700^1 of ethanol was added. Precipitated DNAwas dried, rehydrated in buffer consisting of 10mMTris-HCl (pH 8.0) and 1 mMEDTA,and incubated for 1 hour at 37°C in the presence of 10units ofribonuclease A (RNase A). The purified chromosomal DNAwas analyzed by agarose gel electrophoresis, as described above.
Quantitative Analysis of Cleavable Complex in Nuclei
The amount of cleavable complex was measured by the method of Caldecott et al.16 ) Five thousand CHO-K1cells in 4ml of culture mediumwere seeded in a 6-well plate. After 24-hours incubation, the cells were labeled with 2.5 iuCi/ml of [6-3H]thymidine and incubated for another 24hours. One hour prior to drug treatment, the label was removed, the cells were washed once with phosphate buffered saline (PBS), and fresh medium was added. These log phase cells were then treated with each drug for 1 hour, after which they were washed with ice-cold PBS and lysed with 500/il prewarmed (60°C) lysis solution consisting of 1.25% SDS, 5mMEDTA,and 0.4mg/ml salmon sperm DNA.The lysed cells were carefully passed 15 times through a 0.4-mm-diameter needle. Prewarmed (37°C) 325 mMKC1 (250^1) was then added, and the tubes were kept on ice for 10minutes. The protein-DNA complex was pelleted by centrifugation for 10minutes at 4°C. The supernatant was carefully removed and the precipitate was resuspended in l ml of prewarmed (37°C) wash solution consisting of 10mM Tris-HCl (pH 7.5), 100mM KC1, 2mM EDTA, and O.l mg/ml salmon sperm DNAby heating at 60°C for 10minutes with periodic mixing. The tubes were then transferred to ice for 10minutes and the cycle was repeated once. Finally, the protein-DNA complex was dissolved in 100 /xl of distilled water at 50°C and added to 4ml of scintillant. Radioactivitity was measured with a liquid scintillation counter (Beckmann LS6000TA).
Competition of DNABinding with Ethidium Bromide (EtBr) DNAbinding of TAN-1518A was analyzed by an EtBr competition assay.5) Sample solution (10/il) was mixed with 100fi\ of5^m EtBr arid 40^m (in base) salmon sperm DNAin a buffer consisting of 50him Tris-HCl (pH 7.5), 100 mMNaCl, and 1 mMEDTA.The fluorescence intensity of the solution was measured with a fluorescence concentration analyzer (Baxter Pnadex FCA-VIP); excitation wavelength was 545 nm for competition of EtBr versus TAN-1 5 1 8 A, 4'-(9-acridinylamino)methanesulfon-ra-anisidine (m-AMSA) or actinomycin D, and 300nmfor competition between EtBr and adriamycin; emission wavelength was 575 nm for all competitors.
Cell Cycle Analysis HeLa S3 cells (5 x 105) in 10ml of culture medium were seeded in a plate (9-cm diameter). After 24-hours incubation, each drug was added and the cells were incubated for another 24 hours. The following procedures were carried out at room temperature: The cells were harvested and resuspended in 180 /zl of a lysis buffer consisting of 0.03 mg/ml trypsin, 0.5 mMTris-HCl (pH 7.6), 3.4mM trisodium citrate, 0.1% Nonidet P-40 (NP-40), and 1.5mM spermine. After 10minutes, 150/il of a nuclease buffer, consisting of 0.1 mg/ml RNase A, 0.5 mg/ml trypsin inhibitor, 0.5 mMTris-HCl (pH 7.6), 3.4mM trisodium citrate, 0.1 % NP-40, and 1.5 mMspermine was added, and the suspension was left to stand for 10 minutes. The resulting nuclei were stained with 150 /il of dye buffer consisting of 2 mg/ml propidium iodide (PI), 0.5 mMTris-HCl (pH 7.6), 3.4mM trisodium citrate, 0.1% NP-40, and 4.8mM spermine for 10minutes. After filtration through a nylon mesh, the Pi-stained cells were subjected to flow cytometric analysis with a FACScan (Beckton-Dickinson) and the percentage of cells in each phase of the cell cycle was determined by analysis of DNAhistograms of 1 x 104 cells, using the Cell-fit program (Beckton-Dickinson).
Inhibition of Macromolecular Syntheses
The effects of TAN-1518A on DNA,RNA,and protein synthesis was determined by measuring the amounts of radiolabeled precursors incorporated into HeLa S3 cells. The cells (1 x 103/well) in 0.1 ml of culture medium were seeded in a 96-well plate. After 24-hours incubation, TAN-1518A was added, and the cells were incubated for a further 18hours after which they were treated with O.l juCi/ml of [6-3H] 
in the last 2hours of incubation. The culture supernatant was then discarded, and monolayer cells were washed twice with PBSand treated with trypsin-EDTA solution, consisting of 0.25% trypsin and 0.02% EDTA,at 37°C for 10minutes. The cells were harvested on glass fiber filter disks and washed twice with PBS; radioactivity associated with the filter disks was measured with a liquid scintillation counter (Beckman LS6000TA).
Antimicrobial Activity
The antimicrobial activity of TAN-1518A was determined by the agar dilution method. Antibiotic medium 3 supplemented with yeast extract 0.5% was used for commonbacteria; trypticase soy agar (TSA) supplemented with glycerol 3% was used for acid-fast bacteria; and TSA supplemented with glucose 1 % was used for yeasts and fungi. Bacteria were grown at 37°C for 18 hours, and yeasts and fungi were grown at 28°C for 48hours. 
Results
Taxonomy of the Producing Organism Strain AL-16012was isolated from a soil sample collected in Amino-cho, Takeno county, Kyoto prefecture, Japan. Whole-cell analysis of the strain showed the presence of LL-diaminopimelic acid.
The aerial mycelia of the strain were gray. Each spore chain of this strain was bent and spiral, and consisted of about 10~50 spores, which were cylindrical and had a smooth surface (Plate 1). No soluble pigment production was observed. Theculture and physiological characteristics of the strain are shown in Table 1 .
These characteristics of strain AL-16012 indicate that it belongs to the genus Streptomyces. Therefore, the strain was namedStreptomyces sp.
AL-16012 and has been deposited in the Institute for Fermentation, Osaka under the accession No. Production and Isolation TAN-1518A and B were produced by culturing strain AL-16012. The production of the major metabolite, TAN-1518 A, reached a maximum(87/*g/ml) at 138 hours after inoculation.
TAN-1518 components consist of three compounds, A (1), B (2) and X (3). Since they are fat-soluble and weakly acidic, the acidified culture broth was extracted with EtOAc. The organic layer was then washed with aqeous NaHCO3 and water and concentrated. The residue was chromatographed on a silica gel column, giving 1 and 3. A minor constituent, 2, was purified by preparative HPLC, using a column of octadecylsilane (ODS).
Chemical Characterization and Determination of Structure Compounds 1 and 2 were soluble in MeOH, CHC13, EtOAc, and Me2CO, but insoluble in water and hexane. They gave positive color reactions with potassium permanganate, phosphomolybdic acid, and sulfuric acid, and negative color reaction with ninhydrin and Dragendorff reagents. The physicochemical properties of TAN-1518 A (1) and B (2) are summarized in Table 2 . The molecular formulae were determined to be C39H41NO15for 1 and C41H45NO15for 2, on the basis of elemental analyses, mass spectra, and 13C NMRspectra. The IR spectra in KBr showed the absorption bands at 3410cm"1 (NH and OH), 1720 (sh, ester), 1660 (amide). The UV spectra resembled those of tetracyclines.
The XH and 13C NMRdata are summarized in Tables 3 and 4 . The signals were assigned based on 2D NMRexperiment, i.e.,^^H correlation spectroscopy (COSY), *H-13C COSY, and long range^-^C COSY. These spectra indicated the presence of C-glycoside, salicylic acid, and 2-methyl-2-butenoic acid moieties in 1 and 3. In fact, alkaline hydrolysis of 1 with 1 n NaOHfor 6hours at room temperature gave salicylic acid (4) and 2-methyl-2-butenoic acid (5) . The configuration of the double bond in 5 was determined to be Z, by comparing the chemical shift of /f-methyl carbon (3 20.3) in 5 (angelic acid and that in tiglic acid ([E~]-2-methyl-2-butenoic acid, 3 1 1.5).
From its physico-chemical properties, we determined that compound 3 was identical to SF2575,9) a tetracycline antibiotic with C-glycoside, salicylic acid, and angelic moieties. Compound1 was structurally similar to 3; we compared its physico-chemical properties with those of 3, and found that one of the two methoxy groups observed in 3 was not observed in 1. A long-range coupling was found between the methoxy protons (6-OCH3, 3 3.20) and C-6 (3 77.9). Further, the chemical shift of C-12a (3 75.1) in 1 showed an May be interchangeable. up field shift by 5.8 ppm, compared with the corresponding carbon (3 80.9) in 3. Thus, 1 was determined to be 12a-0-demethyl compound 3. Compound2 was also structurally similar to 1. The differences between 2 and 1 were found in the angelic acid moiety and the methoxy group. Comparing the 13C NMR spectra, a methylene carbon signal at 27.0 ppm was observed in 2. The proton signal at 1.88ppm (3H, s, 5"-CH3) of 1 was missing, and signals at 2.24ppm (2H, m, -CH2-) and 1.01 ppm (3H, t, /=7.4Hz, -CH3) were observed in 2. Furthermore, in the NOESYexperiment of 2, a cross peak was observed between the methyl signal (3 1.01) and the olefin signal at 6.02ppm (1H, q, /=7.2Hz). From these results, we determined that 2 had a (Z)-2-ethyl-2-butenoic acid moiety instead of angelic acid. Further, methoxy protons (12a-OCH3, 3 3.52) correlated to C-12a (3 80.9) in the COLOCspectrum were observed in 2. Thus, the structure of 2 was determined, as shown in Fig. 1 .
Biological Activity The inhibitory activity of TAN-1518 A on the relaxation of plasmid DNAby Topo I is shown in Fig. 2. TAN-1518 A inhibited the Topo I activity in a dose-dependent manner; partial inhibition was observed even at a concentration as low as 2.5^m. The inhibitory activity was virtually comparable to that of CPT, a specific inhibitor of Topo I. The inhibitory activity of TAN-1518B was slightly weaker than that of TAN-1 518 A (Table 5 ). These findings demonstrate that both metabolites are potent inhibitors ofTopoI. Electrophoresis was carried out in a 0.7% agarose gel with 0.1% SDS at 100 volts for 35 minutes. Lane A, ccc DNAcontrol; lane B, relaxed DNAcontrol; lanes C to H, TAN-1518 A; lanes I to N, CPT. Drug concentrations were: lanes C and I, 100/iM; lanes D and J, 50fiM; lanes E and K, 25/^m; lanes F and L. 10um: lanes G and L. 5um: lanes H and N. 2.5um. and A31, 2x 104/ml; HeLa S3, WiDr, A549, and G361, 4x 104/ml; B16, 5x 104/ml; SW48, 1 x 105/ml. Fig. 3 . Effects of TAN-1518 A on the decatenation activity of calf thymus Topo II.
Electrophoresis was carried out in a 1.0% agarose gel with 0.1% SDS at 100 volts for 20 minutes. Lane A, catenated kDNAcontrol; lane B, decatenated minicircle control; lanes C to G, ra-AMSA;lanes H to L, TAN-1518A. Drug concentrations were: lanes C and H, 125fiM; lanes D and I, 62.5jUM; lanes E and J, 31.3/zm; lanes F and K, 15.7fiw, lanes G and L, 7.9fjM. To determine whether or not these metabolites were specific inhibitors of Topo I, we examined the effect of TAN-1518A on the decatenation of kDNA by Topo II. TAN-1518 A slightly inhibited the enzyme activity at a concentration of 62.5 /zm, whereas ra-AMSA, a specific inhibitor o Topo II, inhibited the activity even at the concentration of 7.9/jm (Fig. 3) . This indicates that the activity of TAN-1518 A is relatively specific to Topo I. Similar results were also obtained using TAN-1518 B.
The modeof action of these metabolites was investigated by the following studies; we used the major metabolite TAN-1518A because of its stronger inhibitory activity against Topo I. The cytotoxicity of TAN-1518A is shown in Table 6 . This metabolite strongly suppressed the growth of all tumor cell lines tested.
The morphology of HeLa S3 cells treated with TAN-1518 A is shown in plate 2. The treated cells formed typical apoptotic bodies in which surface microvilli were lost. Similar results were also obtained with SW48cells (data not shown). To confirm the induction of apoptosis, we extracted chromosomal DNAfrom the nuclei of tumor cells treated with TAN-1518 A and analyzed it by agarose gel electrophoresis. DNA fragmentations corresponding to the nucleosomal ladders were detected in all cell lines tested (Fig. 4) . These findings indicate that TAN-1518A strongly induces apoptosis in tumor cells. Most topoisomerase inhibitors inhibit the enzyme by stabilizing the enzyme-DNAreaction intermediate cleavable complex.2) In our experiments, TAN-1518A did not increase the protein-DNA complex in the nuclei of CHO-K1cells at the concentrations tested, whereas CPT and ra-AMSA,both of which stabilize the cleavable complex, increased the complex in a dose-dependent manner (Fig. 5) . These findings indicate 1, no drug control; 2, TAN-1518 A, 50nM; 3, TAN-1518 A, 200nM; 4, TAN-1518 A, Ijum; 5, CPT, 20nM; 6, CPT, 50nM; 7, CPT, 100nM.
that TAN-1518 A inhibits Topo I in a different manner from CPT.
To determine whether TAN-1518 A had the ability to intercalate into DNA strands, we employed an EtBr-competition assay with salmon sperm DNA.This metabolite weakly reduced the fluoresence intensity of EtBr (Fig. 6) The antimicrobial activity of TAN-1518 A is shown in Table 7 . This metabolite was weakly active against some Gram-positive bacteria but showed no antimicrobial activity against Gram-negative bacteria, acid-fast bacteria, yeasts, or fungi.
In vivo antitumor activity was tested in an experimental murine tumor model. MethAfibrosarcoma cells (1 x 106 per mouse) were implanted subcutaneously in CDF1mice and tumor weight was measured on day 10. TAN-1518 A (lOmg/kg) given intraperitoneally on day 1 and day 2 significantly suppressed the growth of Meth A tumor (T/C=57%).
Discussion
Wehave described here the novel Topo I inhibitors, TAN-1518A and B, which belong to the tetracycline family. 18) TAN-1518 A was shown to predominantly impair the uptake of [6-3H]thymidine in HeLacells, to strongly suppress the growth of various tumor cells, and to induce apoptosis in these cells. These findings imply that the inhibitory activity of these metabolites against Topo I may be involved in the apoptotic cell death of tumor cells.19'20) These metabolites also showed weak inhibitory activity against Topo II; this phenomenon may be due to their weak activity in intercalating into DNAstrands.
Unlike CPT, TAN-1518 A did not stabilize the cleavable complex in the nuclei of HeLa cells. 21~25) Further, this metabolite prevented the death of yeast cells caused by CPT (data to be published elsewhere). These findings suggest that TAN-1518 A may inhibit some earlier steps that occur before cleavable complex formation in the catalytic cycle of Topo I.24'25) These metabolites would therefore be expected to be useful for clarifying the function of Topo I. TAN-1518A arrested HeLa cells in Gl phase of the cell cycle, and this indicates that Topo I may play a crucial role in this phase of the mammaliancell cycle.
